Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Table 4 Assessment of platelet activity and reactivity in patients and controls

				Patient group	Control group	Test value	p-value
Platelet marker	CD41		Mean ± SD	93.8 ± 7.2	92.7 ± 12.5	T = 0.5	0.3
Platelet activation (in vivo)		Baseline CD62P %	Mean ± SD	32.82 ± 13	25.77 ± 10	T = 3.28	0.001*
Platelet activation (in vivo)		Baseline CD62P MFI	Mean ± SD	103.6 ± 40.6	79.1 ± 35.2	T = 3.5	0.001*
Platelet reactivity (in vitro)		ADP induced CD62P%	Mean ± SD	72.95 ± 14.8	62.2 ± 11.39	T = 4.4	< 0.0001*
Platelet reactivity (in vitro)		ADP induced CD62P MFI	Mean ± SD	248 ± 101	215 ± 75.8	T = 2	0.04*

*In dependent Student’s T-test is significant at level of significance of 95% (p < 0.05). CD cluster of differentiation, ADP adenosine di-phosphate
bold indicates statistically significant relation
italic indicates the type of the test used